Upregulation of VEGF-A Without Angiogenesis in a Mouse Model of Dilated Cardiomyopathy Caused by Mitochondrial DysfunctionEmma Thama, Jianming Wanga, Fredrik Piehlb, and Günther Weberaa Department of Molecular Medicine, Karolinska Institutet, Stockholm, Sweden b Department of Medicine, Karolinska Institutet, Stockholm, Sweden Correspondence to: Emma Tham, Dept. of Molecular Medicine, CMM L8:02, Karolinska Institutet, 171 76 Stockholm, Sweden. E-mail: emma.tham@cmm.ki.se
Angiogenesis is implicated in a variety of human pathologies and may also play a role in the progression of heart failure. We have studied the expression of members of the vascular endothelial growth factor (VEGF) and the angiopoietin families and their receptors in mice lacking the mitochondrial transcription factor A. These mice lack functional respiratory chain activity in their myocytes and develop dilated cardiomyopathy (DCM) postnatally. We studied the hearts of the knockout mice by in situ hybridization, Western blotting analysis, and immunohistochemistry. VEGF-A mRNA and protein levels were elevated in the myocardium of the knockouts. Levels of the hypoxia inducible transcription factor 1 alpha (HIF1
Key Words:
dilated cardiomyopathy, mitochondria, in situ hybridization, VEGF, HIF1
This article has been cited by other articles:
|
|
||||||||||||||||||||||||||||||||||||||